CYP is in the process of a CR at a discounted rate of 21.5c and SHs are dreaming of hitting 20c in the near future.
Ask yourselves this: Given the current position you are in and what month we are in, how was CYP management still nominating to potentially start the GVHD trial by 2022 end, at the last AGM in Nov 2022?
I've underlined and bolded the word how for dramatic effect.
The BoDs were oblivious to the notion that the GVHD was going to cost money and no one was offering to pay for the trial and only in recent weeks/months has it dawned on them that money is in fact needed to progress trials, after all?
Really? Because, in hindsight, it looks like the BoDs and management were treMENDously mistaken. Again.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)